Mission & Principles
Documents by category: Articles
Low anti-tuberculosis drug concentrations in HIV-Tuberculosis co-infected adults with low body weight; is it time to update dosing guidelines?
Published in Antimicrobial Agents and Chemotherapy on March 12, 2019
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study.
Published in Clinical Pharmacology & Therapeutics on February 8, 2019
Virological Outcome of Patients With HIV Drug Resistance Attending an Urban Outpatient Clinic in Uganda: A Need for Structured Adherence Counseling and Third-Line Treatment Options.
Published in JAIDS on April 1, 2019
Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland.
Published in Journal of Antimicrobial Chemotherapy on February 1, 2019
Comparison of Löwenstein-Jensen and BACTEC MGIT 960 culture for Mycobacterium tuberculosis in people living with HIV.
Published in HIV Medicine on April 25, 2018;
Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort.
Published in Plos One on November 1, 2018
High efavirenz serum concentrations in TB/HIV-coinfected Ugandan adults with a CYP2B6 516 TT genotype on anti-TB treatment.
Published in Journal of Antimicrobial Chemotherapy on Jan 1, 2019
HIV-1 Drug Resistance Among Ugandan Adults Attending an Urban Out-Patient Clinic.
Published in JAIDS on August 15, 2018
Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.
Published in Clinical Infectious Diseases on September 1, 2018
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study.
Published in BMJ Open on July 10, 2017